Publications - Discoveries and Innovations from Incucyte

0
Total number of publications
0
Number of publications this year
Displaying 680 results out of a total of 3930 publications.

Filter publications:

Search publications:

The omentum promotes ovarian cancer cell survival by increasing cell cycle duration and chemoresistance
Cardenas, C;Alvero, AB;Pitruzzello, M;Tedja, R;Mor, GG;
Cancer Research, Cancer Research 77(13):1995, 2017
View publication
microRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi
Zhao, Z;Partridge, V;Sousares, M;Shelton, SD;Holland, CL;Pertsemlidis, A;Du, L;
PLoS ONE, PLoS ONE 13(12):e0208777, 2018
View publication
Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells
Brer, A;Gauthier-Coles, G;Rahimi, F;van Geldermalsen, M;Dorsch, D;Wegener, A;Holst, J;Brer, S;
J. Biol. Chem., J. Biol. Chem. ():, 2019
View publication
Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: Possible mechanisms and approaches for overcoming PDT-resistance
Olsen, CE;Weyergang, A;Edwards, VT;Berg, K;Brech, A;Weisheit, S;Hgset, A;Selbo, PK;
Biochem. Pharmacol., Biochem. Pharmacol. ():, 2017
View publication
Molecular characterization of an MLL1 fusion and its role in chromosomal instability
Parameswaran, S;Vizeacoumar, FS;Kalyanasundaram Bhanumathy, K;Qin, F;Islam, MF;Toosi, BM;Cunningham, CE;Mousseau, DD;Uppalapati, MC;Stirling, PC;Wu, Y;Bonham, K;Freywald, A;Li, H;Vizeacoumar, FJ;
Mol Oncol, Mol Oncol ():, 2018
View publication
CD95/Fas ligand mRNA is toxic to cells
Putzbach, W;Haluck-Kangas, A;Gao, QQ;Sarshad, AA;Bartom, ET;Stults, A;Qadir, AS;Hafner, M;Peter, ME;
Elife, Elife 7():, 2018
View publication
Cell-derived matrices for studying cell proliferation and directional migration in a complex 3D microenvironment
Kaukonen, R;Jacquemet, G;Hamidi, H;Ivaska, J;
Nat Protoc, Nat Protoc 12(11):2376-2390, 2017
View publication
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival
McClurg, UL;Azizyan, M;Dransfield, DT;Namdev, N;Chit, NCTH;Nakjang, S;Robson, CN;
Oncotarget, Oncotarget 9(38):24992-25007, 2018
View publication
HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-based PET Imaging
Martins, CD;Da Pieve, C;Burley, TA;Smith, R;Ciobota, DM;Allott, L;Harrington, K;Oyen, WJG;Smith, G;Kramer-Marek, G;
Clin. Cancer Res., Clin. Cancer Res. ():, 2018
View publication
IDH3 regulates one-carbon metabolism in glioblastoma
May, JL;Kouri, FM;Hurley, LA;Liu, J;Tommasini-Ghelfi, S;Ji, Y;Gao, P;Calvert, AE;Lee, A;Chandel, NS;Davuluri, RV;Horbinski, CM;Locasale, JW;Stegh, AH;
Sci Adv, Sci Adv 5(1):eaat0456, 2019
View publication
No file selected
0%
Stay up-to-date with what's happening at Essen BioScience

© 2024 Essen BioScience

Privacy Policy